Sanara MedTech Faces Securities Fraud Probe After $31.2M Loss on Program Shutdown
Schall Law Firm investigates $SMTI for potential fraud following discontinuation of Tissue Health Plus program, which triggered $31.2M loss and 24.7% stock plunge.
SMTIsecurities fraudclass action lawsuit